Skip to main content

Table 2 Clinical and laboratory characteristics of survivors and non-survivors at 28 days

From: Impact of non-dialysis chronic kidney disease on survival in patients with septic shock

 

Survivors

Non-survivors

p

n=70

n=93

Male gender

44 (63%)

49 (53%)

0.2

Age (years)

64 (53–74)

71 (59–77)

0.01

Diabetes

23 (33%)

28 (30%)

0.9

HBP

39 (56%)

58 (62%)

0.4

Heart failure

9 (13%)

17 (18%)

0.4

Peripheral artery disease

12 (17%)

13 (14%)

0.8

Coronary artery disease

11 (16%)

17 (18%)

0.8

COPD

15 (21%)

12 (13%)

0.2

Statin use

18 (26%)

23 (25%)

0.9

Baseline eGFR (ml/min/1.73m2)

78 (61–106)

63 (38–82)

0.001

CKD

17 (24%)

39 (42%)

0.03

Scr on admission (μmol/l)

209 (122–409)

290 (175–426)

0.15

Scr at onset of septic shock (μmol/l)

232 (117–384)

270 (174–396)

0.2

Hb on admission (g/dl)

10.5 (8.2-12.7)

10 (8.8-11.7)

0.4

SAPS II

50 (40–62)

68 (56–90)

<0.001

Days w/o catechol (days)

8 (3–14)

0 (0–2)

<0.001

Days w/o MV (days)

5 (2–8)

0 (0–1)

<0.001

Length of stay, days

12 (6–25)

4 (1–10)

<0.001

RIFLE Classification

59 (44%)

76 (56%)

0.08

  Risk

14 (56%)

11 (44%)

0.7

  Injury

14 (54%)

12 (46%)

0.8

  Failure

27 (35%)

51 (65%)

0.009

  Loss of function

4 (67%)

2 (33%)

0.7

  ESKD

-

-

-

  1. Reported as the number (%) or the median (IQR).
  2. Scr serum creatinine, CKD chronic kidney disease (Baseline eGFR < 60ml/min/1.73m2), BMI body mass index, HBP High blood pressure, SAPS II Simplified Acute Physiologic Score II, adm. admission, GFR glomerular filtration rate, MV mechanical ventilation, catechol. catecholamines.